The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zofenil Plus 30 mg/12.5 mg film-coated tablets

30 mg/12.5 milligram(s) Film-coated tablet

Menarini International Operations Luxembourg S.A.PA0865/012/001

Main Information

Trade NameZofenil Plus 30 mg/12.5 mg film-coated tablets
Active SubstancesZofenopril calcium
Strength30 mg/12.5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/012/001

Group Information

ATC CodeC09BA ACE inhibitors and diuretics
C09BA15 zofenopril and diuretics


Licence Issued13/05/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back